ask="2.7100"
ask_size="4800"
average_daily_volume="501156"
bid="2.3000"
bid_size="500"
book_value="3.5610"
change="-0.0449"
change_from_200_day_moving_average="-2.0835"
change_from_50_day_moving_average="0.2422"
change_from_52_week_high="-6.6999"
change_From_52_week_low="0.6501"
change_in_percent="-1.6660%"
close="2.6501"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.0310"
ebitda="-31.76M"
eps_estimate_current_year="-1.1600"
eps_estimate_next_quarter="-0.2800"
eps_estimate_next_year="-0.8000"
ex_dividend_date="N/A"
float_shares="8386000"
high="2.7200"
high_52_weeks="9.3500"
last_trade_date="3/6/2017"
last_trade_price="2.6501"
last_trade_size="167"
last_trade_time="3:57pm"
low="2.6400"
low_52_weeks="2.0000"
market_capitalization="41.49M"
moving_average_200_day="4.7336"
moving_average_50_day="2.4079"
name="Nivalis Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.6300"
open="2.7000"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-44.0145%"
percent_change_from_50_day_moving_average="+10.0567%"
percent_change_from_52_week_high="-71.6567%"
percent_change_from_52_week_low="+32.5050%"
previous_close="2.6950"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.7568"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="15656000"
short_ratio="0.6800"
stock_exchange="NGM"
symbol="NVLS"
volume="68500"
weeks_range_52="2.0000 - 9.3500"
